Stamatios Chalvatzis
Overview
Explore the profile of Stamatios Chalvatzis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dolapsakis C, Karofylakis E, Chalvatzis S
Eur J Case Rep Intern Med
. 2025 Feb;
12(2):005169.
PMID: 39926576
Learning Points: Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a class of medications that cause secondary hyperparathyroidism.In patients with normocalcemic primary hyperparathyroidism, SGLT2 inhibitor' initiation can cause overt hyperparathyroidism and hypercalcemia.We propose...
2.
Adami M, Kotsaki A, Antonakos N, Giannitsioti E, Chalvatzis S, Saridaki M, et al.
Crit Care
. 2024 Feb;
28(1):42.
PMID: 38321472
Background: Sepsis guidelines suggest immediate start of resuscitation for patients with quick Sequential Organ Failure Assessment (qSOFA) 2 or 3. However, the interpretation of qSOFA 1 remains controversial. We investigated...
3.
Karakike E, Dalekos G, Koutsodimitropoulos I, Saridaki M, Pourzitaki C, Papathanakos G, et al.
J Innate Immun
. 2021 Dec;
14(3):218-228.
PMID: 34852352
Background: Macrophage activation-like syndrome (MALS) and complex immune dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to investigate the effect of personalized immunotherapy on clinical improvement...
4.
Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos G, Poulakou G, Gatselis N, et al.
Elife
. 2021 Mar;
10.
PMID: 33682678
Background: It was studied if early suPAR-guided anakinra treatment can prevent severe respiratory failure (SRF) of COVID-19. Methods: A total of 130 patients with suPAR ≥6 ng/ml were assigned to...